Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ImmunoGen Inc. logo

ImmunoGen Inc.

Sector: Healthcare   

Industry: Biotechnology

31.23
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 8,315 M  90-day average vol: 2,775,484

Previous close: 31.23  Open: 0.0  Bid:   Ask:
52 week range    
3.99   
   31.25
Peers   
SGEN / 
AMGN / 
JNJ / 
PARD / 
NVS / 
LLY / 
RHHBY / 
SNY / 
BMY / 
Last updated: Wednesday 24th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AMGN

0.0347129 B23.4223.53

BMY

0.0332145 B-27.366.19

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

NVS

PARD

PFE

0.0302298 B15.153.21

RHHBY

SGEN

25 B-72.7140.79

SNY

Financials

IMGN Income Statement

Annual
Jun-13Jun-14Jun-15Jun-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends5 M20 M
Basic EPS from continuing operations-0.7-0.25-0.68-0.88
Basic EPS total-0.7-0.25-0.68-0.88
Basic weighted shares outstanding84 M85 M86 M87 M98 M140 M148 M176 M206 M254 M
Cost of sales-810000.0-661000.0-1 M-1 M-1 M
Depreciation-5 M-5 M-6 M-5 M-6 M-7 M4 M2 M2 M2 M
DepreciationAndAmortization-5 M-5 M-6 M-5 M-6 M-7 M4 M2 M2 M2 M
Diluted EPS total-0.87-0.83-0.71-1.67-0.98-1.21-0.7-0.25-0.68-0.88
Diluted normalized net income/share-1.21-0.68-0.88
Diluted weighted shares outstanding84 M86 M78 M87 M98 M140 M148 M176 M206 M254 M
Earnings from equity interest27 M
EarningsFromEquityInterestNetOfTax27 M
GainOnSaleOfPPE21000.0-20000.0-7000.021000.0-239000.0-115000.0-2 M691000.0
GainOnSaleOfSecurity197000.02000.04 M729000.051000.04 M
GeneralAndAdministrativeExpense21 M24 M28 M37 M34 M37 M38 M39 M44 M116 M
Gross operating profit36 M60 M86 M8 M1 M82 M132 M70 M109 M
ImpairmentOfCapitalAssets3 M
Income before tax-73 M-71 M-55 M-125 M-82 M-158 M-87 M-21 M-139 M-222 M
Income restructuring and M&A779000.04 M21 M1 M
Income taxes4 M4 M3 M8 M-97 M11 M-7 M-2 M-7 M1 M
Interest income3 M
InterestExpenseNonOperating138000.03 M95000.095000.095000.047000.0
MiscOtherSpecialCharges72000.0123000.0-916000.0117000.094 M53 M590000.0481000.0-1 M-994000.0
Net income from total operations-73 M-71 M-55 M-145 M-96 M-169 M-104 M-44 M-139 M-223 M
NetIncomeCommonStockholders-73 M-71 M-61 M-145 M-96 M-169 M-104 M-44 M-126 M-218 M
NetIncomeContinuousOperations-73 M-71 M-55 M-145 M-96 M-169 M-104 M-44 M-139 M-223 M
NetIncomeFromOtherGainsLosses-20 M-14 M-11 M-17 M-23 M-13 M
NetNonOperatingInterestIncomeExpense126000.044000.069000.0187000.0-2 M4 M-95000.0-95000.0-47000.0
Normalized income-147 M-175 M
Operating income-73 M-72 M-54 M-177 M-174 M-211 M-92 M-22 M-125 M-221 M
Operating income before depreciation (EBITDA)-68 M-67 M-50 M-119 M-73 M-151 M-86 M-22 M-140 M-223 M
OperatingExpense-109 M-131 M-140 M-185 M-174 M211 M174 M155 M195 M330 M
Other income net-72000.0-123000.0916000.0-52 M-94 M-53 M-5 M-1 M1 M-3 M
OtherGandA21 M24 M28 M37 M34 M37 M38 M39 M44 M116 M
OtherImpairmentOfCapitalAssets-180000.0694000.0
OtherOperatingExpenses-109 M-131 M-140 M-185 M-174 M-215 M4 M4 M4 M-176000.0
OtherunderPreferredStockDividend5 M20 M
PreferredStockDividends5 M20 M
RealizedCapitalGain25 M
RentAndLandingFees21 M24 M28 M37 M34 M-8 M
Research & development expense87 M107 M112 M148 M140 M174 M115 M115 M151 M213 M
ResearchExpense87 M107 M112 M148 M140 M174 M115 M115 M151 M213 M
RestructringAndMnAIncome779000.04 M21 M1 M
Revenue per share-205000.0334000.0
SalariesAndWages-16 M-16 M-22 M-11 M-16 M
Selling Gen & administrative expense21 M24 M28 M37 M34 M37 M38 M39 M44 M116 M
Special income/charges-779000.0-4 M-21 M-1 M
Total Income available for interest expense (EBIT)-73 M-71 M-55 M-125 M-79 M-158 M-87 M-21 M-139 M-222 M
Total common shares outstanding85 M86 M87 M87 M133 M149 M174 M200 M221 M226 M
Total net income-73 M-71 M-55 M-145 M-96 M-169 M-104 M-44 M-139 M-223 M
Total ordinary shares266 M266 M266 M266 M266 M266 M266 M266 M266 M266 M
Total revenues36 M60 M86 M8 M32 M82 M132 M70 M109 M
TotalExpenses-109 M-132 M-141 M185 M-176 M211 M174 M155 M195 M330 M
TotalRevenue36 M60 M86 M60 M115 M82 M132 M70 M109 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University